Center for Health Promotion and Prevention Research, The University of Texas School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
National Healthy Start Association, Washington, DC, USA.
Psychooncology. 2022 Oct;31(10):1681-1691. doi: 10.1002/pon.6026. Epub 2022 Sep 14.
To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID-19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the pandemic.
We analyzed data from the 2019 (n = 856) and 2020 (n = 626) Health Information National Trends Survey, a nationally representative survey of United States adults aged ≥18 years. Only adults with a cancer diagnosis were used in the analyses. Anxiety/depression was assessed using the Patient Health Questionnaire-4 (low/none [0-2], mild [3-5], moderate [6-8], and severe [9-12]) and dichotomized as low/none and current anxiety/depression (mild/moderate/severe). Multivariate analysis was performed.
The prevalence of anxiety/depression symptoms among cancer patients was 32.7% before the COVID-19 pandemic and 31.1% during the pandemic. The odds of anxiety/depression among patients with fair/poor health status was higher during the pandemic relative to before (before: odds ratio [OR] = 1.85 vs. during: OR = 3.89). Participants aged 50-64 years (before: OR = 0.29, 95% confidence interval [95% CI] = 0.11-0.76; during: OR = 0.33, 95% CI = 0.11-0.97) and ≥65 years (before: OR = 0.13, 95% CI = 0.05-0.34; during: OR = 0.18, 95% CI = 0.07-0.47) had lower odds of anxiety/depression before and during the pandemic compared to those aged 35-49 years. Hispanics/Latinos had higher odds of anxiety/depression (OR = 2.70, 95% CI = 1.11-6.57) before the pandemic and lower odds of anxiety/depression during the pandemic (OR = 0.2, 95% CI = 0.05-1.01) compared to non-Hispanic Whites. Those who completed high school (before: OR = 0.08, 95% CI = 0.01-0.42), some college (before: OR = 0.10, 95% CI = 0.02-0.42), ≥college degree had lower odds of anxiety/depression symptoms (before: OR = 0.05, 95% CI = 0.01-0.26; during: OR = 0.06, 95% CI = 0.01-0.61) compared to those with less than a high school education.
Our results suggest the need to increase the provision of mental health services to cancer patients at high risk of developing anxiety/depression symptoms, particularly during public health emergencies, to alleviate further health burdens.
评估癌症患者在 COVID-19 大流行之前(2019 年)和期间(2020 年)焦虑/抑郁症状的患病率差异;以及在大流行之前和期间,癌症患者中焦虑/抑郁与社会人口学和健康行为因素之间的关联。
我们分析了来自 2019 年(n=856)和 2020 年(n=626)健康信息国家趋势调查的数据,这是一项针对美国≥18 岁成年人的全国代表性调查。仅使用患有癌症诊断的成年人进行分析。使用患者健康问卷-4(低/无[0-2]、轻度[3-5]、中度[6-8]和重度[9-12])评估焦虑/抑郁,并将其分为低/无和当前焦虑/抑郁(轻度/中度/重度)。进行了多变量分析。
在 COVID-19 大流行之前,癌症患者焦虑/抑郁症状的患病率为 32.7%,在大流行期间为 31.1%。与大流行前相比,健康状况一般/较差的患者出现焦虑/抑郁的几率更高(大流行前:比值比[OR] = 1.85;大流行期间:OR = 3.89)。50-64 岁(大流行前:OR = 0.29,95%置信区间[95%CI] = 0.11-0.76;大流行期间:OR = 0.33,95%CI = 0.11-0.97)和≥65 岁(大流行前:OR = 0.13,95%CI = 0.05-0.34;大流行期间:OR = 0.18,95%CI = 0.07-0.47)的患者与 35-49 岁的患者相比,出现焦虑/抑郁的几率较低。与非西班牙裔白人相比,西班牙裔/拉丁裔在大流行前出现焦虑/抑郁的几率更高(OR = 2.70,95%CI = 1.11-6.57),在大流行期间出现焦虑/抑郁的几率较低(OR = 0.2,95%CI = 0.05-1.01)。与高中以下学历相比,完成高中学业(大流行前:OR = 0.08,95%CI = 0.01-0.42)、完成一些大学学业(大流行前:OR = 0.10,95%CI = 0.02-0.42)、至少完成大学学业的患者出现焦虑/抑郁症状的几率较低(大流行前:OR = 0.05,95%CI = 0.01-0.26;大流行期间:OR = 0.06,95%CI = 0.01-0.61)。
我们的研究结果表明,需要增加为有发展焦虑/抑郁症状风险的癌症患者提供心理健康服务,尤其是在公共卫生紧急情况下,以减轻进一步的健康负担。